Correlation and immunolocalization of substance P nerve fibers and activated immune cells in human chronic gastritis by Sipos, G et al.
Correlation and Immunolocalization of
Substance P Nerve Fibers and Activated
Immune Cells in Human Chronic
Gastritis
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ABSTRACT
Neuropeptides are able to modulate cytokine production by macro-
phages in response to various stimulators and have a major role in
inflammation of different organs. Mammalian poly (ADP-ribose) polymer-
ase (PARP) and nuclear factor kappa B (NF-jB) both have been suggested
to play a crucial role in inflammatory disorders. Unregulated increase of
tumor necrosis factor-a (TNF-a) may also be pathogenic in inflammatory
diseases. The aim of this study was to investigate the correlation between
the number of Substance P (SP) containing nerve fibers and activated
immune cells using immunohisto-, immunocytochemical (EM) and confo-
cal laser microscopic methods. To investigate expression and activation of
immune cells gastric biopsy samples from patients with chronic gastritis
were used. The number of SP containing nerve fibers and activated
immune cells increased significantly in gastritis. Using monoclonal p65
antibody, activated NF-jB was found in inflamed mucosa but was absent
in uninflamed mucosa. Immunobinding for the activated form of p65 of
NF-jB was found in 22% of macrophages and 45% of lymphocytes. The
number of immune cells showing IR for NF-jB, PARP and TNF-a corre-
lated with the increasing number of SP containing fibres. Confocal laser
microscopy was used to confirm the colocalization of SP in TNF-a and
NFjB positive lymphocytes and mast cells in inflamed mucosa. Immuno-
electronmicroscopic investigation confirmed that these cells belong to lym-
phocytes, mast cells and macrophages. Conclusions: The increase of SP in
nerve fibers and in activated immune cells further activate the production
of other proinflammatory mediators (e.g. TNF-a) and therefore generate
the chronic inflammation. Anat Rec, 291:1140–1148, 2008.  2008
Wiley-Liss, Inc.
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Neuropeptides are able to modulate cytokine produc-
tion by macrophages in response to various stimulators.
Substance P (SP) and calcitonin gene-related peptide
(CGRP) are important mediators of neuroimmunomodu-
latory activity (Veronesi et al., 1999; Azzolina et al.,
2003; Yarace et al., 2003). It was also demonstrated that
SP has a major role in inflammation of the stomach
(Mózsik et al., 2001). Previously we have shown that the
*Correspondence to: Prof. Erzsébet Fehér, Semmelweis Uni-
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number of the SP-immunoreactive (IR) nerve fibers was
increased significantly and that they were morphologi-
cally close to the immune cells during chronic gastritis
(Sipos et al., 2006). The increased number of SP IR
nerve fibers suggests that SP specifically stimulates the
chemotaxis of lymphocytes, monocytes, neutrophils, and
fibroblasts (Kahler et al., 1993; Schratzberger et al.,
1997; O’Connor et al., 2004). Lymphocyte extravasation
is facilitated by neurogenic inflammation and plasma ex-
travasation that are dependent on the release of SP
from capsaicin sensitive primary sensory nerve endings
by means of an axon reflex. SP selectively activates tu-
mor necrosis factor-alpha (TNF-a) gene expression in dif-
ferent mast cells (Ansel et al., 1993; Cocchiara et al.,
1997). Unstimulated peritoneal mast cells spontaneously
released a small quantity of TNF-a, whereas after SP
stimulation the amount of released TNF-a was approxi-
mately four times higher and this effect was inhibited
only by pretreatment with SP antagonist (SPA, P101,
CP-96345; Cocchiara et al., 1999). It is well known that
TNF-a plays a key role in the immunopathogenesis of
inflammatory bowel diseases, a fact which is overtly con-
firmed by clinical effects observed in refractory Crohn’s
disease patients treated with a chimeric monoclonal
antibody against TNF (infliximab; Blam et al., 2001).
The binding of SP to tachykinin-1 receptor can result
in the up-regulation of proinflammatory cytokines, such
as TNF-a and interleukin-8 (IL-8), whose expression is
controlled by the transcription factor NF-kB (Lieb et al.,
1997; Marriott et al., 2000). Activation of the NF-kB/Rel
transcription family, by nuclear translocation of cytoplas-
mic complexes, plays a central role in inflammation
through its ability to induce transcription of proinflam-
matory genes (Baldwin, 1996). NF-kB exists in the cyto-
plasm in an inactive form associated with regulatory pro-
teins called inhibitors of kB (IkB). Phosphorylation of IkB
an important step in NF-kB activation, is mediated by
IkB kinase. The dimer, typically composed of a p50 and
p65 subunit, is translocated to the nucleus after degrada-
tion of the inhibitory I-kB in response to a wide variety of
stimuli (Ghosh et al., 1998). Varro et al. (2004) also dem-
onstrated that in unstimulated cells, p65-dsRed was
located in the cytosol, and stimulation by H. pylori caused
translocation to the nucleus. The activation of transcrip-
tion factor nuclear factor-kB (NF-kB) regulates various
genes involved in the proliferation, invasion, angiogene-
sis, and metastasis of cancer cells. Substantial in vitro
data suggest that activation of NF-kB is a critical initial
step in the inflammatory response. Several studies dem-
onstrated a link between in vivo NF-kB activation accom-
panied by cytokine production and the generation of
inflammation in animal models of inflammatory diseases
(Sakurai et al., 1996; Blackwell et al., 1997; Ellis et al.,
1998). The identification of NF-kB as a key player in the
pathogenesis of inflammation suggests that NF-kB tar-
geted therapeutics might be effective in diseases like gas-
tritis. Inflammation in any part of the gastrointestinal
tract can profoundly influence the function of the mucosal
layer that lies closest to the luminal contents. The inflam-
matory response is coordinated to a large extent by an
array of chemical mediators that are released from
nerves, from the immune cells and epithelium.
Besides of NF-kB the mammalian poly (ADP-ribose)
polymerase (PARP) has been also suggested to play a
crucial role in inflammatory disorders (Hassa and Hot-
tinger, 2002). The activation of PARP is now considered
as a final common effector in various types of tissue
injury including systemic inflammation, circulatory
shock and ischemia/reperfusion (Virág and Szabó, 2002).
The obligatory triggers of PARP activation are DNA sin-
gle string breaks, which can be induced by a variety of
environmental stimuli, most notably hydroxyl radical
and peroxyntirite. Direct and indirect experimental evi-
dence demonstrated that activation of PARP importantly
contributes to the pathophysiology of various forms of
inflammation (Szabó, 1998). PARP inhibition is a suc-
cessful therapeutic concept in the treatment of a wide
variety of inflammatory diseases (Szabó et al., 2004).
It is now clear that Helicobacter pylori (HP) activates
the transcription factor NF-kB and this event plays a
central role in the induction of the inflammatory reac-
tion often associated with colonization with this bacte-
rium. The increase of SP-IR in nerve fibers and immune
cells that parallel with the grade of inflammation in the
stomach has never been described previously. Although,
in recently similar changes in other inflamed organs has
been published, the correlated increase in the substan-
ces described was not observed. Therefore, we have
examined in this study the expression and activation of
NF-kB, TNF-a, PARP and the correlation of SP immuno-
reactive nerve fibers and immune cells in the control
stomach and HP-associated gastritis using light and
electron microscopy as well as confocal laser microscopy.
MATERIALS AND METHODS
Endoscopic biopsies of gastric antrum were obtained
from 10 HP-positive patients (4 male; 6 female, ageing
from 30 to 67 years old) who underwent esophagogastro-
duodenoscopy for dyspeptic symptoms over a period of
1 year. None of the patients had neoplasmic disease or
peptic ulcer. Antral samples of 5 dyspeptics (2 male; 3
female, ranging from 27 to 58 years) obtained with endos-
copy and histologically normal HP negative stomach sam-
ples were used as controls. HP positivity, assessed by rapid
urease test, had been confirmed by histology and serology
in all patients. Biopsies from HP positive patients showed
histologically chronic gastritis with moderate or severe ac-
tivity according to the Sydney’s system (Price, 1991). All
patients and healthy volunteers gave their informed con-
sent according to Semmelweis University guidelines for
ethics in human tissue experiments (No: TUKEB 85/2006).
Immunohistochemical Analysis
Biopsy materials were fixed in Zamboni’s fixative con-
taining 4% paraformaldehyde, 0.1% glutaraldehyde in
250 mL of 0.4 M phosphate-buffer, 150 mL picric acid
(pH 7.3) for 6 hr and placed overnight in glutaralde-
hyde-free fixative containing 20% sucrose at 48C. Sec-
tions (40 mm thick) were treated for 1 hr with 1% TRI-
TON-X 100 to increase membrane permeability and for
15 min with 3% hydrogen peroxide to remove endoge-
nous peroxidase activity. Incubation with primary anti-
sera was performed for 48 hr at 48C. The Avidin-Biotin
technique was employed using a commercially available
kit (Vectastain Elite ABC, Vector Laboratories, Peterbor-
ough, UK) for the immunostaining. All manipulations
were performed at room temperature. Immunoreactivity
was visualized with diamino-benzidine (DAB) chromogen
reaction (Dako, Milan, Italy) (0.025% 3, 3-diamino-benzi-
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dine, 0.0015% H2O2 in 0.05 M Tris-HCl buffer, pH 7.5)
for 8 to 10 min, at room temperature. For light micro-
scopic examination the sections were mounted on gelati-
nized slides, air-dried, cleared, and covered with Depex.
To block nonspecific binding of antibody, sections were
preincubated with 1:10 diluted normal goat serum.
Antibodies
Antibody to Substance P (SP) was developed in rabbit
(Peninsula Lab. Inc., San Carlos, CA), dilution:
1:10,000). Antisera to NF-kB subunits, anti-p65 mouse
monoclonal IgG (Chemicon, International Inc., Teme-
cula, CA), dilution: 1:1,500; which recognizes an epitope
overlapping the nuclear location signal of the p65 subu-
nit of NF-kB heterodimer. The anti-human TNF-a poly-
clonal antibody developed in rabbit (Sigma-Aldrich),
dilution: 1:8,000, anti-PARP mouse monoclonal antibody
(Biomol Int. LP, Plymouth Meeting, PA), dilution:1:500.
For double staining the sections were also examined by
confocal laser microscopy (Nikon Eclipse 800 microscope,
Japan, Radiance 2100, Bio-Rad, LaserSharp2000 Soft-
ware, Bio-Rad House, Hertfordshire, UK). Frozen sections
were washed in phosphate buffered saline (PBS) at room
temperature and permeabilized for 20 min in PBS
(23NaCl) containing 0.3% Triton X-100 and 2% normal
serum; the same solution was used to dilute the antibod-
ies. Afterward, they were sequentially incubated with
anti-SP antiserum at dilution 1:5,000 overnight. Slides
were washed in PBS and then incubated for 3 hr at room
temperature with a secondary fluorescein (FITC, 1:100)
conjugated donkey anti-rabbit IgG antibody (Jackson
ImmunoResearch, West Grove, PA). The sections were
washed with buffer and incubated with anti–TNF-a
(1:8,000) for 24 hr, followed by secondary antiserum
raised in donkey fluorescein-labeled anti-rabbit IgG,
Alexa 594, diluted in 1:500, Molecular Probes, Eugene,
OR) for 3 hr, mounted in anti-fade medium (Vectashield,
Vector Laboratories, Peterborough, UK) and stored at
2208C until needed. The cell bodies and the nerve fibers
that could be followed were then scanned with a confocal
laser microscope equipped with a krypton–argon laser.
Fluorescent signals from FITC (green) and Alexa 594
(red) were sequentially detected on a Bio-Rad MicroRa-
diance confocal laser system (Bio-Rad MRC1024).
For electron microscopic investigations the sections
were post-fixed in osmium and embedded in Epon.
Fig. 1. Cross-section of the stomach glands from gastritis. Numer-
ous immunoreactive SP nerve fibers (arrow) and SP-positive immuno-
cytes (arrowheads) are located among the glands. Scale bar 5 100 mm.
Fig. 2. Changes of the SP-IR nerve fibers in the human gastritis.
Fig. 3. Changes of the activated immune cells in the human gastritis.
Fig. 4. A part of the tunica mucosa from gastritis. Arrows point
TNF-a–IR immunocytes beneath the glands. Gl, glands; MM, lamina
muscularis mucosae. Scale bar 5 100 mm.
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Ultrathin sections were cut and stained with uranyl ace-
tate and lead citrate and photographed in a Jeol 1OO
electron microscope.
Activation Score
To assess the activity of NF-kB, PARP and TNF-a in
situ in the human stomach, specimens from all patients
were stained for the previous antibodies. Three view fields
of each section were investigated at 3200 magnification
(0.0325 mm2/viewfield), and positive cells were counted,
blind to the clinical diagnosis. The average of the three
fields was taken as the activation score of the specimen.
To be able to compare the results between patients, it was
ensured that all sections visualized the entire axis from
the superficial epithelium to the muscularis mucosae.
Control Experiments
Specificity of the immunoreactivity was controlled by
omission of the primary antiserum or, when the sections
were incubated in antisera, preabsorbed with excess
antigen, where no immunostaining appeared.
Fig. 5. Tunica mucosa from human gastritis. Arrows show the
strong positive poly(ADP-ribose) staining in the cell nuclei of immune
cells. Scale bar 5 100 mm.
Fig. 6. A part of the mucosa of the inflamed human stomach. Arrows show the active NF-kB immu-
noreactivity in the nucleus of the immune cells. Scale bar 5 100 mm.
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Statistical Analysis
Data are presented as mean 6 scanning electron mi-
croscopy. Comparisons between groups of data were
made using a one-way analysis of variance followed by a
Tukey post hoc test. P values < 0.05 were considered
statistically significant.
RESULTS
All subjects were of adult age and no predominance of
male or female sex was present. At endoscopy gastric
hyperemia was the main feature of HP-related chronic
gastritis.
The number of SP IR nerve fibers was increased sig-
nificantly, also some immune cells (lymphocytes, plasma
cells, macrophages, and mast cells) showed immunoreac-
tivity for SP (Fig. 1). The gap between the nerve termi-
nals and immune cells was approximately 1 mm or even
less. The change of the number of SP-IR nerve fibers is
shown on Figure 2.
In the control materials the number of PARP- and
TNF-a–IR cells was very low, in some sections totally
missing. However, in sections from chronic gastritis
their number was significantly increased (P < 0.001)
(Fig. 3). PARP and TNF-a staining in gastritis were
localized primarily to the mononuclear cells and fibro-
blasts in the lamina propria, with no detectable staining
of the epithelium (Figs. 4, 5). These IR immune cells
were in close contact with epithelial cells. The reaction
end-product of PARP was seen in the nuclei of the cells,
while TNF-a immunoreactivity was observed in the cyto-
plasm of the positive cells. According to the size and
form of these IR cells they belong to the lymphocytes,
macrophages and polymorphonuclear cells (PMN).
In the normal stomach, low and moderate immunor-
eactivity of NF-kB (p65 subunit) was found in the cyto-
plasm of gastric glandular epithelial cells located in the
deep region of the glands. In gastritis, the active NF-kB
was observed in clusters of inflammatory cells, where
NF-kB was detected not only in large amounts in the
cytoplasm but also in the nucleus, suggesting activation
of NF-kB in these cells (Fig. 6). The number of active
NF-kB IR cells was markedly increased, as compared
with uninflamed tissue, and they were mainly detected
among the glands. 22% of mast cells and 45% of lympho-
cytes were immunoreactive in gastritis.
Confocal laser microscope investigations showed that
dense green reaction end products (FITC) were distrib-
uted in the SP containing nerve fibers and throughout
the cytoplasm of immune cells (SP); some of these
showed a red reaction (Alexa 594) for TNF-a (Fig. 7).
Fluorescent double-labeled immunostaining showed that
SP (FITC, green) fluorescence positive immune cells also
had immunostaining for p65 of NF-kB (Alexa 594, red),
where their labeling was located in the nucleus of these
cells (Fig. 8).
The electron-microscopic investigation proved that
these cells belong to different immunocompetent cells
(lymphocytes, macrophages and mast cells). The reaction
Fig. 7. Confocal images illustrating of SP-IR nerve cells and acti-
vated immune cells in the human gastritis. a: SP-IR immune cells
(arrows) in the lamina propria among the glands. Arrowhead shows the
SP-IR nerve fibers close to the activated mast cells. b: The arrows
show the same mast cells showing immunoreactivity for TNF-a. c:
Arrows indicate double-labeling immune cells for SP and TNF-a. Scale
bar 5 50 mm.
Fig. 8. Confocal images illustrating of SP and NF-kB immune cells
in the human gastritis. Fluorescent double-labeled immunostaining
showed that SP (FITC) fluorescence-positive immune cells were also
labeled for NF-kB, where the immunostaining (Alexa 594, red) was
located in the nucleus of these cells. In the insert, one of the double-
labeled mast cell. a: Arrows point the SP mast cells and arrowhead
show a SP lymphocyte. b: The arrows and arrowhead show the same
cells showing immunoreactivity for NF-kB. c: Arrows indicate the
double-labeling cells for SP and NF-kB. Scale bar 5 50 mm.
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end products were distributed in the cytoplasm and at
the membranes of the TNF-a–IR cells (Figs. 9, 10), while
in NF-kB–IR cells, the reaction end products were
located in the nucleus of the cells (Fig. 11) reflecting
activation of the NF-kB heterodimer.
DISCUSSION
SP is involved in the biological activities of the
immune system, including the induction of cytokines in
immune cells (Lee et al., 1994; Ho et al., 1996; Cocchiara
et al., 1997; Maggi, 1997). It was demonstrated that the
number of SP-IR nerve fibers and SP IR immune cells
increased significantly during inflammation in the
tongue and in the stomach (Batbayer et al., 2004; Sipos
et al., 2006). SP degranulates mast cells and, therefore,
further amplifies the inflammatory reactions. Capsaicin
pretreatment (which decreases or eliminates the func-
tional contribution of C-fiber nociceptors) decreases
phagocyte migration into inflammation sites and pre-
vents degranulation of mast cells (Perretti et al., 1993).
Antagonists of pro-inflammatory peptides such as SP
may control inflammatory diseases or processes in which
these peptides have a primary pathogenic role (Frieri,
2003).
SP-stimulation of murine mast cells activates TNF-a
gene expression and induces TNF-a secretion (Ansel
et al., 1993). It was also demonstrated by Azzolina et al.
(2003) that the NFkB pathway is involved in the tran-
scriptional regulation of the TNF-a and IL-6 over
expression in SP-stimulated mast cells. SP also activates
the transcription factor NFkB, a threefold increased nu-
clear translocation being observed in alveolar macro-
phages from healthy smokers (Bardelli et al., 2005). Our
previous data and this study showed that Helicobacter
pylori caused continuous infiltration of inflammatory
cells and significant increase of SP IR nerve terminals
as well as the SP immunoreactive immune cells (Sipos
et al., 2006). Therefore, we have postulated that during
the early events of an inflammatory process induced by
neuropeptide SP could be the cause of the increase in
TNF-a in the inflamed organs. The increased production
of TNF-a might activate the NF-kB in the cells of the
mucosa as well as it further activates the PARP which
causes injury to the mucosal lining (Fig. 12).
PARP activation was identified as a key pathway in
different pathophysiological conditions and disease
states. Recent reports have shown that PARP can act as
a coactivator of NFkB (Hassa and Hottinger, 2002). The
cleaved form of PARP is catalytically inactive. Depend-
ing on the severity of DNA damage, genotoxic stimuli
can trigger three different pathways. In the case of mild
DNA damage, PARP facilitates DNA repair and thus
survival. More severe DNA damage induces enzymes of
the apoptotic cell death during which caspases, the main
executor enzymes of apoptotic process, inactivate PARP
cleaving into two fragments (p89 and p24). The most
severe DNA damage may cause excessive PARP activa-
Fig. 11. Electron microscopic photograph of a NF-kB immunoreac-
tive lymphocyte from the inflamed stomach. The reaction end-prod-
ucts are located in the nucleus (arrow) showing the activation of this
cell. Scale bar 5 1 mm.
Fig. 10. Electron microscopic photograph of a TNF-a–IR mast cell
from the gastritis. Scale bar 5 1 mm.
Fig. 9. Electron microscopic photograph of a TNF-a–IR granulo-
cyte from the gastritis. Note that the reaction end-products are visible
in the cytoplasm of the cell (arrows). Scale bar 5 1 mm.
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tion inhibiting glycolysis and mitochondrial respiration
and depleting NAD1 and ATP stores (Szabó et al., 1997,
2002). Our histological examination clearly demon-
strated that significant PARP activation occurs in the
mucosa of the stomach during chronic inflammation. In-
hibition of PARP reduces the infiltration of neutrophils,
decreases inflammatory infiltrate, which would be asso-
ciated with a reduction in both oxygen and nitrogen cen-
tered free radical production (Szabó et al., 1997).
Our data indicate that immune cells (mast cells, lym-
phocytes, macrophages) are the most prominent cell
types exhibiting activated NF-kB in the inflamed mu-
cosa, where their number was increased in chronic gas-
tritis. This is in agreement with the findings of Rogler
et al. (1998) in patients with inflammatory bowel dis-
eases, who showed that NF-kB was mainly activated in
macrophages and epithelial cells. There is evidence of
NF-kB activation in inflammatory bowel disease, where
the lamina propria macrophages display activated p50,
c-Rel, and p65 (Neurath et al., 1996). Reed et al. (2005)
demonstrated that NF-kB activation increased signifi-
cantly biphasically (temporal activation) in experimen-
tal colitis. Helicobacter pylori-associated gastritis in
previous studies exhibited increased NF-kB activity in
gastric epithelial cells, where the number of NF-kB–
positive cells correlates with the degree of gastritis
(Van Den Brink et al., 2000). It is now recognized that
activation of NF-kB induces many different genes, some
of which are associated with inhibition of apoptosis and
others with innate immunity and inflammatory
Fig. 12. Postulated mechanisms of gastric mucosal injury.
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responses (Hassa and Hottinger, 2002). It was also
demonstrated that PARP-1 can act as a coactivator of
NF-kB. Secretion of pro-inflammatory cytokines by
recruited inflammatory cells leads to continued stimu-
lation of epithelial and endothelial cells that in turn
might activate the NF-kB/PARP-1 complexes. Thus, a
positive autoregulatory loop might be established that
can amplify the inflammatory response and increase
the duration of chronic inflammation resulting in a per-
sistent activation of NF-kB/PARP-1 complexes charac-
terized by overexpression of pro-inflammatory media-
tors. It was proposed that disrupting the physical inter-
action of PARP-1 and NF-kB might inhibit the
abnormal transcriptional activity of NF-kB, thereby
reducing the inflammatory response at the level of
transcription in instances where this process becomes
chronic or dysregulated (Hassa and Hottinger, 2002).
NF-kB directed therapy was demonstrated to be effec-
tive in a model of inflammatory bowel disease induced
by 2,4,6-trinitrobenzene sulfonic acid. It was also
shown that selective TNF receptor inhibition may be
advantageous with anti-TNF treatments in combating
chronic inflammatory disease (Kollias, 2005). The treat-
ment of patients with rheumatoid arthritis with anti-
bodies against TNF-a can control refractory disease
(Elliott et al., 1994). Single intraperitoneal injection of
anti–TNF-a monoclonal antibody treatment signifi-
cantly reduced serum/tissue TNF-a and improved indo-
methacin-induced enteropathy in rats by modulating
iNOS expression (Saud et al., 2005). Our data indicate
and suggest that TNF signaling system mediates muco-
sal damage by the enhancement of NF-kB activity par-
allel with increased number of SP nerve fibers and
immune cells and that they may be the key pathoge-
netic factor of gastritis. TNF-a may influence the sever-
ity of disease, possibly by the persistent activation of
NF-kB.
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Szabó C. 1998. Role of poly(ADP-ribose)synthase in inflammation.
Eur J Pharmacol 350:1–19.
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